BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26247039)

  • 1. The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity.
    McGarry N; Greene CM; McElvaney NG; Weldon S; Taggart CC
    J Immunol Res; 2015; 2015():507315. PubMed ID: 26247039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
    Taggart CC; Cryan SA; Weldon S; Gibbons A; Greene CM; Kelly E; Low TB; O'neill SJ; McElvaney NG
    J Exp Med; 2005 Dec; 202(12):1659-68. PubMed ID: 16352738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
    J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
    Taggart CC; Greene CM; McElvaney NG; O'Neill S
    J Biol Chem; 2002 Sep; 277(37):33648-53. PubMed ID: 12084717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
    McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
    Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
    Nugteren S; Simons-Oosterhuis Y; Menckeberg CL; Hulleman-van Haaften DH; Lindenbergh-Kortleve DJ; Samsom JN
    Eur J Immunol; 2023 Feb; 53(2):e2249964. PubMed ID: 36480463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells.
    Greene CM; McElvaney NG; O'Neill SJ; Taggart CC
    Infect Immun; 2004 Jun; 72(6):3684-7. PubMed ID: 15155685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts.
    Kikuchi T; Abe T; Yaekashiwa M; Tominaga Y; Mitsuhashi H; Satoh K; Nakamura T; Nukiwa T
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):364-70. PubMed ID: 10970828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
    Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response.
    Odaka C; Mizuochi T; Yang J; Ding A
    J Immunol; 2003 Aug; 171(3):1507-14. PubMed ID: 12874244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
    Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.
    Antoniades CG; Khamri W; Abeles RD; Taams LS; Triantafyllou E; Possamai LA; Bernsmeier C; Mitry RR; O'Brien A; Gilroy D; Goldin R; Heneghan M; Heaton N; Jassem W; Bernal W; Vergani D; Ma Y; Quaglia A; Wendon J; Thursz M
    Hepatology; 2014 Apr; 59(4):1564-76. PubMed ID: 24282114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
    Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
    Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
    Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
    Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.
    Nakamura K; Takamoto N; Hongo A; Kodama J; Abrzua F; Nasu Y; Kumon H; Hiramatsu Y
    Oncol Rep; 2008 May; 19(5):1085-91. PubMed ID: 18425362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory leukocyte protease inhibitor in cancer development.
    Devoogdt N; Revets H; Ghassabeh GH; De Baetselier P
    Ann N Y Acad Sci; 2004 Dec; 1028():380-9. PubMed ID: 15650263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases.
    Wex T; Treiber G; Venerito M; Leodolter A; Peitz U; Kuester D; Hritz I; Krueger S; Roessner A; Malfertheiner P
    Biol Chem; 2006 Jul; 387(7):893-901. PubMed ID: 16913839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
    Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
    J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of secretory leucocyte protease inhibitor (SLPI) in human pancreatic beta-cells.
    Nyström M; Bergenfeldt M; Ljungcrantz I; Lindeheim A; Ohlsson K
    Mediators Inflamm; 1999; 8(3):147-51. PubMed ID: 10704052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
    Rao NV; Marshall BC; Gray BH; Hoidal JR
    Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.